Skip to content
value.today

Rapid Pathogen Screening Inc

Total raised
$30 M
4 rounds on record
Latest round
$6 M
Jul 2013
First round on record
Jan 2009
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Rapid Pathogen Screening Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2013$6 MNo. 4$2 to $10 million

Rapid Pathogen Screening Inc: Raise no. 4, Jul 2013

Investors in this round

1 investor had bought by the notice of Jul 22, 2013: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $10 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$1,300,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • J. Scott Womble · Executive Officer
  • Robert Sambursky · Executive Officer, Director
  • Robert VanDine · Executive Officer, Director
  • Caroline T. Popper · Director
  • Charles T. Saldarini · Director
  • Daniel Sambursky · Director
  • Jules Musinger · Director
  • Stephen R. La Neve · Director
  • Thomas Orsini · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by J. Scott Womble, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 22, 2013. Read the notice at the SEC.

debt, optionsSEC
Oct 2012$2 MNo. 3$2 to $10 million

Rapid Pathogen Screening Inc: Raise no. 3, Oct 2012

Investors in this round

25 investors had bought by the notice of Jul 22, 2013: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $15 M offered; $13 M still to sell
Smallest investment taken
$49,950
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$700,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • J. Scott Womble · Executive Officer
  • Robert Sambursky · Executive Officer, Director
  • Robert VanDine · Executive Officer, Director
  • Caroline T. Popper · Director
  • Charles T. Saldarini · Director
  • Daniel Sambursky · Director
  • Jules Musinger · Director
  • Stephen R. La Neve · Director
  • Thomas Orsini · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The offering is completed.”

Signed by J. Scott Womble, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 22, 2013. Read the notice at the SEC.

equitySEC
Sep 2010$7 MNo. 2$2 to $10 million

Rapid Pathogen Screening Inc: Raise no. 2, Sep 2010

Investors in this round

57 investors had bought by the notice of Oct 10, 2012: 57 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $22 M offered; $15 M still to sell
Smallest investment taken
$49,950
What was sold
equity
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$1,228,200 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • J. Scott Womble · Executive Officer
  • Robert Sambursky · Executive Officer, Director
  • Robert VanDine · Executive Officer, Director
  • Thomas Orsini · Executive Officer, Director
  • Daniel Sambursky · Director
  • Douglas W. Berg · Director
  • Jules Musinger · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “This offering is completed.”
  • On the use of proceeds: “Represents budgeted salaries and budgeted bonuses until break-even.”

Signed by J. Scott Womble, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Oct 10, 2012. Read the notice at the SEC.

equitySEC
Jan 2009$15 MNo. 1$10 to $50 million

Rapid Pathogen Screening Inc: Raise no. 1, Jan 2009

Investors in this round

71 investors had bought by the notice of Feb 9, 2010: 71 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
$25,000
What was sold
equity, debt
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
$345,388 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • J. Scott Womble · Executive Officer
  • Robert Sambursky · Executive Officer, Director
  • Robert VanDine · Executive Officer, Director
  • Thomas Orsini · Executive Officer, Director
  • Daniel Sambursky · Director
  • Jose Scott Sambursky · Director
  • Jules Musinger · Director
  • Michael Strauss · Director
  • William Rueckert · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “"""Total Offering Amount"" includes $3.0 million in convertible notes offered and ""Total Amount Sold"" includes $1.0 million in convertible notes sold."”

Signed by J. Scott Womble, Chief Financial Officer. Source: SEC Form D, newest notice filed Feb 9, 2010. Read the notice at the SEC.

equity, debtSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Rapid Pathogen Screening Inc chose not to state its revenue in its newest notice of a funding round (Jul 2013).

    SEC Form D · Jul 2013

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jul 2013

That is all the official record says: Rapid Pathogen Screening Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Rapid Pathogen Screening Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 71 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Rapid Pathogen Screening Inc
NameRoleNamed in
J. Scott WombleExecutive officerJul 2013
Robert SamburskyExecutive officerJul 2013
Robert VanDineExecutive officerJul 2013
Thomas OrsiniExecutive officerOct 2012
Caroline T. PopperDirectorJul 2013
Charles T. SaldariniDirectorJul 2013
Daniel SamburskyDirectorJul 2013
Jules MusingerDirectorJul 2013
Robert SamburskyDirectorJul 2013
Robert VanDineDirectorJul 2013
Stephen R. La NeveDirectorJul 2013
Thomas OrsiniDirectorJul 2013
Douglas W. BergDirectorOct 2012
Jose Scott SamburskyDirectorFeb 2010
Michael StraussDirectorFeb 2010
William RueckertDirectorFeb 2010